Related Experiment Video
Updated: Jul 2, 2026

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
Published on: February 28, 2025
[Treatment of smoking cessation during pregnancy]
1Department of Chest Diseases, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey. fundaoztuna@meds.ktu.edu.tr
Active and passive smoking during pregnancy is an important health problem. The majority of pregnant smoker women continue smoking during pregnancy. Because of the serious risks of tobacco to both mother and fetus, effective behavioral interventions and pharmacotherapy are needed to help pregnant smokers. Pharmacotherapy may useful smoking cessation in pregnancy, but may be the potential harmful effects of medication on the fetus. The very few studies exist that have studied the safety and efficacy of medications to treat pregnant smokers. The treatments for the use pregnancy smokers were summarized in this review.
Active and passive smoking during pregnancy is an important health problem. The majority of pregnant smoker women continue smoking during pregnancy. Because of the serious risks of tobacco to both mother and fetus, effective behavioral interventions and pharmacotherapy are needed to help pregnant smokers. Pharmacotherapy may useful smoking cessation in pregnancy, but may be the potential harmful effects of medication on the fetus. The very few studies exist that have studied the safety and efficacy of medications to treat pregnant smokers. The treatments for the use pregnancy smokers were summarized in this review.
Related Concept Videos
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
CNS Depressants: Alcohol and Nicotine
Asthma-IV: Nursing Management
First, in...
Stress Prevention and Stress Management Techniques IV